| 1 |
Human host-defense peptide LL-37 targets stealth siderophores
Zsila F, Beke-Somfai T
Biochemical and Biophysical Research Communications, 526(3), 780, 2020 |
| 2 |
Electrochemical and AFM study of the interaction of recombinant human cathelicidin LL-37 with various supported bilayer lipid membranes
Gal M, Sokolova R, Naumowicz M, Hives J, Krahulec J
Journal of Electroanalytical Chemistry, 821, 40, 2018 |
| 3 |
The modulatory effect of TLR2 on LL-37-induced human mast cells activation
Zhang YY, Yu YY, Zhang YR, Zhang W, Yu B
Biochemical and Biophysical Research Communications, 470(2), 368, 2016 |
| 4 |
Human cathelicidin LL-37 inhibits platelet aggregation and thrombosis via Src/PI3K/Akt signaling
Su W, Chen YH, Wang CH, Ding X, Rwibasira G, Kong Y
Biochemical and Biophysical Research Communications, 473(1), 283, 2016 |
| 5 |
Recombinant expression of novel protegrin-1 dimer and LL-37-linker-histatin-5 hybrid peptide mediated biotin carboxyl carrier protein fusion partner
Orrapin S, Intorasoot S
Protein Expression and Purification, 93, 46, 2014 |
| 6 |
Human antimicrobial peptide LL-37 modulates proinflammatory responses induced by cytokine milieus and double-stranded RNA in human keratinocytes
Chen X, Takai T, Xie Y, Niyonsaba F, Okumura K, Ogawa H
Biochemical and Biophysical Research Communications, 433(4), 532, 2013 |
| 7 |
Alarin but not its alternative-splicing form, GALP (Galanin-like peptide) has antimicrobial activity
Wada A, Wong PF, Hojo H, Hasegawa M, Ichinose A, Llanes R, Kubo Y, Senba M, Ichinose Y
Biochemical and Biophysical Research Communications, 434(2), 223, 2013 |
| 8 |
Production of human antimicrobial peptide LL-37 in Escherichia coli using a thioredoxin-SUMO dual fusion system
Li YF
Protein Expression and Purification, 87(2), 72, 2013 |
| 9 |
Expression of a novel dual-functional protein - The antimicrobial peptide LL-37 fused with human acidic fibroblast growth factor in Escherichia coli
Shen J, Lu XM, Jin XB, Ding J, Li XB, Mei HF, Chu FJ, Zhu JY
Protein Expression and Purification, 81(1), 119, 2012 |
| 10 |
A novel protocol for the production of recombinant LL-37 expressed as a thioredoxin fusion protein
Li YF
Protein Expression and Purification, 81(2), 201, 2012 |
